Latest Breaking News On - Polypeptide group - Page 2 : comparemela.com

PolyPeptide announces results of the annual General Meeting 2024

Medacta : 2023 Corporate Governance -March 13, 2024 at 02:08 am EDT

CORPORATE GOVERNANCE REPORT Medacta s Annual Report 2023 INDEX .

PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow

PolyPeptide Group / Key word: Annual Results PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash.

Global Cell Penetrating Peptide Market to Reach $8.40 Billion by 2030 Owing To Increasing Demand for Targeted Drug Delivery Systems

/PRNewswire/ Coherent Market Insights published a report, titled, Global Cell Penetrating Peptide Market, By Type (Protein Derived CPPs, Synthetic CPPs,.

Hedge Funds Watching Drug Makers | Law Street Media